These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11850703

  • 1. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
    Suehiro A, Sawada A, Hasegawa Y, Takatsuka H, Higasa S, Kakishita E.
    Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
    [Abstract] [Full Text] [Related]

  • 2. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB, Naik UP, Markell MS, Kornecki E.
    Cell Mol Biol Res; 1993 Jan; 39(3):265-74. PubMed ID: 7507391
    [Abstract] [Full Text] [Related]

  • 3. Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).
    Fox SC, Judge HM, Allen BR, Heptinstall S.
    Platelets; 2002 Jun; 13(4):213-8. PubMed ID: 12189022
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation.
    Naik UP, Markell M, Ehrlich YH, Kornecki E.
    Cell Mol Biol Res; 1993 Jun; 39(3):257-64. PubMed ID: 8293040
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine A affects serotonergic mechanisms in uremic rats.
    Krygicz D, Azzadin A, Pawlak R, Małyszko JS, Pawlak D, Myśliwiec M, Buczko W.
    Pol J Pharmacol; 1996 Jun; 48(3):351-4. PubMed ID: 9112676
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of immunosuppressive drugs on COX-2 activity in vitro and in kidney transplant patients in vivo.
    Jespersen B, Thiesson HC, Henriksen C, Therland K, Falk C, Poulsen T, Fogh B, Madsen K, Walther S, Jensen BL.
    Nephrol Dial Transplant; 2009 May; 24(5):1644-55. PubMed ID: 19193738
    [Abstract] [Full Text] [Related]

  • 7. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G, Akay OM, Kus E, Bal C, Yalcin AU, Gulbas Z.
    Ren Fail; 2009 May; 31(2):111-7. PubMed ID: 19212907
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J.
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of human platelet aggregation and secretion induced by rapamycin.
    Babinska A, Markell MS, Salifu MO, Akoad M, Ehrlich YH, Kornecki E.
    Nephrol Dial Transplant; 1998 Dec; 13(12):3153-9. PubMed ID: 9870481
    [Abstract] [Full Text] [Related]

  • 10. Detection of platelet aggregates with a particle counting method using light scattering.
    Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S.
    Anal Biochem; 1994 May 01; 218(2):284-94. PubMed ID: 8074282
    [Abstract] [Full Text] [Related]

  • 11. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
    Nowaczyk M, Stephień-Sopniewska B, Korczak-Kowalska G, Mrowiec T, Górski A.
    Arch Immunol Ther Exp (Warsz); 1995 May 01; 43(5-6):329-32. PubMed ID: 8744655
    [Abstract] [Full Text] [Related]

  • 12. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S.
    Am J Ophthalmol; 2004 Nov 01; 138(5):809-17. PubMed ID: 15531317
    [Abstract] [Full Text] [Related]

  • 13. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
    Reis F, Teixeira de Lemos E, Almeida L, Parada B, Garrido AP, Rocha-Pereira P, Santos-Silva A, Santos-Dias J, Dinis A, Figueiredo A, Costa-Almeida C, Mota A, Teixeira F.
    Transplant Proc; 2007 Oct 01; 39(8):2501-6. PubMed ID: 17954158
    [Abstract] [Full Text] [Related]

  • 14. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
    Pelekanou V, Trezise AE, Moore AL, Kay JE.
    Transplant Proc; 1991 Dec 01; 23(6):3200-1. PubMed ID: 1721408
    [No Abstract] [Full Text] [Related]

  • 15. The use of laser-light scattering and controlled shear in platelet aggregometry.
    Hubbell JA, Pohl PI, Wagner WR.
    Thromb Haemost; 1991 May 06; 65(5):601-7. PubMed ID: 1871723
    [Abstract] [Full Text] [Related]

  • 16. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
    Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z.
    Clin Nephrol; 2011 Sep 06; 76(3):218-25. PubMed ID: 21888859
    [Abstract] [Full Text] [Related]

  • 17. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
    Michal F, Motamed M.
    Br J Pharmacol; 1975 Jun 06; 54(2):221P-222P. PubMed ID: 1148513
    [No Abstract] [Full Text] [Related]

  • 18. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF, May JA, Heptinstall S.
    Thromb Res; 2005 Jun 06; 115(4):301-7. PubMed ID: 15668190
    [Abstract] [Full Text] [Related]

  • 19. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA, Mikhailidis DP.
    Clin Appl Thromb Hemost; 2008 Jul 06; 14(3):295-302. PubMed ID: 18445610
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine enhances platelet procoagulant activity.
    Tomasiak M, Rusak T, Gacko M, Stelmach H.
    Nephrol Dial Transplant; 2007 Jun 06; 22(6):1750-6. PubMed ID: 17308321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.